About this trial
The invistigators hypothesized that a protocolized OFA technique would lower the occurance of PONV in patients undergoing thoracoscopic lung surgery compared to standard opioid-based anaesthesia.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Eligible participants were adults (18-80 years).
Prepared for elective thoracoscopic lobectomy or segmentectomy for lung cancer under general anaesthesia
Disqualifiers
Contraindication to any study drug (e.g., heart block, severe liver disease, allergy).
Chronic opioid use (>30 MME/day for >3 months).
Patients with renal impairment (e GFR <30 mL/min).
Pregnancy.
Trial design
Parallel
Treatments tested in this trial
Opioid Free Anaesthesia
DrugThe OFA group protocol consists of a combination of intravenous lidocaine, ketamine, dexmedetomidine, and propofol TIVA.
conventential opioid-based anaesthesia (OBA,
DrugThe OBA group protocol consists of balanced anaesthesia with fentanyl plus sevoflurane.
Treatment groups
Trial outcomes
Primary outcomes
the occurrence of PONV during the initial 24 hours
Secondary outcomes
total opioid consumption over 24 hour (expressed as morphine milligram equivalents.
pain intensity scores (numerical rating scale NRS 0-10)
recovery quality (QoR-15 score)
Locations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: